Lysogene is a phase 3 gene therapy platform company targeting central nervous system (CNS) diseases, developing gene therapies for rare and non-curable diseases
Lysogene is a phase 3 gene therapy platform company targeting central nervous system (CNS) diseases, developing gene therapies for rare and non-curable diseases.